Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H.
Sarah B MulkeyBruria Ben-ZeevJoost NicolaiJohn L CarrollSabine GrønborgYong-Hui JiangNishtha JoshiMegan KellyDavid A KoolenMohamad A MikatiKristen ParkPhillip L PearlIngrid E SchefferRebecca C SpillmannMaurizio TaglialatelaSilvia ViekerSarah WeckhuysenEdward C CooperMaria Roberta CilioPublished in: Epilepsia (2017)
Heterozygous KCNQ2 R201C and R201H gain-of-function variants present with profound neonatal encephalopathy in the absence of neonatal seizures. Neonates present with nonepileptic myoclonus that is often misdiagnosed and treated as seizures. Prognosis is poor. This clinical presentation is distinct from the phenotype associated with loss-of-function variants, supporting the value of in vitro functional screening. These findings suggest that gain-of-function and loss-of-function variants need different targeted therapeutic approaches.